Benzinga | Aug 25, 2021 07:20AM EDT

Raymond James Maintains Outperform on Medtronic, Raises Price Target to $142

Raymond James analyst Jayson Bedford maintains Medtronic (NYSE:MDT) with a Outperform and raises the price target from $135 to $142.